(Q32026925)

5 July 2017

Effects of peroral and transdermal oestrogen replacement therapy on glucose and insulin metabolism (English)

1 reference

5 July 2017

1 reference

Karjalainen A

1

1 reference

5 July 2017

Paassilta M

2

1 reference

5 July 2017

Heikkinen J

3

1 reference

5 July 2017

Bäckström AC

4

1 reference

5 July 2017

Savolainen M

5

1 reference

5 July 2017

Kesäniemi YA

6

1 reference

5 July 2017

language of work or name

1 reference

1 February 2001

1 reference

5 July 2017

Clinical Endocrinology

1 reference

5 July 2017

54

1 reference

5 July 2017

2

1 reference

5 July 2017

165-173

1 reference

Effects of low doses of transdermal 17 beta-estradiol on carbohydrate metabolism in postmenopausal women

5 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01208.X

The effect of transdermal 17-beta-estradiol on glucose metabolism of postmenopausal women is evident during the oral but not the intravenous glucose administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01208.X

Insulin-like growth factor I and its binding proteins in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01208.X

Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01208.X

Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01208.X

Effects of estrogen dose and smoking on lipid and lipoprotein levels in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01208.X

Role of the insulin-like growth factors in the endocrine control of glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01208.X

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01208.X

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01208.X

GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01208.X

Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01208.X

Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01208.X

Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01208.X

The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01208.X

Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01208.X

Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01208.X

10.1046/J.1365-2265.2001.01208.X

21 January 2018

Identifiers

DOI

1 reference

5 July 2017

1 reference